Publication | Open Access

A multicenter randomized clinical trial comparing paclitaxel–cisplatin–etoposide versus cisplatin–etoposide as first-line treatment in patients with small-cell lung cancer

Paclitaxel–cisplatin–etoposide Versus Cisplatin–etoposideMedicineMetronomic TherapyClinical TrialsBronchial NeoplasmCancer TreatmentOncologyRadiation OncologySmall-cell Lung CancerLung CancerMolecular OncologyRadiologyHealth Sciences